300.68
전일 마감가:
$297.59
열려 있는:
$294.27
하루 거래량:
642.40K
Relative Volume:
0.66
시가총액:
$21.24B
수익:
$3.22B
순이익/손실:
$542.70M
주가수익비율:
40.20
EPS:
7.4805
순현금흐름:
$458.00M
1주 성능:
-1.79%
1개월 성능:
+18.97%
6개월 성능:
+6.60%
1년 성능:
+43.00%
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services Inc
|
300.68 | 21.24B | 3.22B | 542.70M | 458.00M | 7.4805 |
|
ISRG
Intuitive Surgical Inc
|
457.78 | 162.13B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
149.31 | 42.47B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
MDLN
Medline Inc
|
44.75 | 37.84B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ALC
Alcon Inc
|
74.09 | 36.11B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
205.02 | 29.87B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
This pharma stock is soaring after earnings. It’s a sneaky GLP-1 play. - MSN
West Pharmaceutical: Multiple Growth Drivers Are A Tailwind (NYSE:WST) - Seeking Alpha
WST stock jumps on Q1 earnings & sales beat, EPS view up on HVP growth - MSN
West Pharma jumps as packaging components drive strong Q1 beat - MSN
Insider Selling: West Pharmaceutical Services (NYSE:WST) CAO Sells 896 Shares of Stock - MarketBeat
West Pharmaceutical Services Reclaims Momentum with Q1 2026 Earnings Beat - HarianBasis.co
WST | West Pharmaceutical Services, Inc. Insider Trading - Quiver Quantitative
West Pharmaceutical sr. VP Annette Favorite sells $859,753 in shares By Investing.com - Investing.com South Africa
West Pharmaceutical sr. VP Annette Favorite sells $859,753 in shares - Investing.com
West Pharmaceutical Services Sr. VP & Chief HR Officer Sold Shares Worth Over $859K - TradingView
WST chief accounting officer Chad Winters sells $269,399 in stock - Investing.com
West Pharmaceutical (WST) Upgraded to Strong Buy: Here's What You Should Know - Yahoo! Finance Canada
Are You Looking for a Top Momentum Pick? Why West Pharmaceutical Services (WST) is a Great Choice - Yahoo Finance
Best Momentum Stocks to Buy for April 29th - Yahoo Finance
WST Stock Price, Quote & Chart | WEST PHARMACEUTICAL SERVICES (NYSE:WST) - ChartMill
WST Price Today: West Pharmaceutical Services, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
A Look at West Pharmaceutical Services Inc (WST) After 3.3% Decl - GuruFocus
West Pharmaceutical Services, Inc.: - marketscreener.com
West Pharmaceutical Services Inc (WST) Stock Price, Trades & News - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services : Selecting a Prefillable Syringe System with Confidence Q&A - marketscreener.com
From Slide to Surge: How West Pharmaceutical Services Reclaimed Its Mojo in 2026 - AOL.com
Trends and Strategies in the 2026 Medical Device CMDO Market: Revenue to Exceed $354 Billion by 2033 - GlobeNewswire Inc.
WST Stock Price Prediction 2025-2026 | West Pharmaceutical Services Inc Forecast | 24/7 Wall St. - 24/7 Wall St.
West Pharmaceutical Services, Inc. $WST Shares Sold by Vest Financial LLC - MarketBeat
West to Participate in Upcoming Investor Conferences (2026-04-28) - Seeking Alpha
West to Participate in Upcoming Investor Conferences - Sahm
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Raises Target Price to $315 - Moomoo
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST): Barclays Lowers Price Target - GuruFocus
West Pharmaceutical Services CEO Eric Green plans to retire after successor is named - MSN
Here's why West Pharmaceutical Services (WST) is a strong growth stock - MSN
Barclays Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Maintains Target Price $310 - Moomoo
West Pharmaceutical Services (WST) Stock Analysis: Exploring a 14% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
West Pharmaceutical signals 2026 revenue of $3.295B-$3.35B and adjusted EPS of $8.40-$8.75 driven by HVP components momentum - MSN
symbol__ Stock Quote Price and Forecast - CNN
West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
West Pharmaceutical Services, Inc. $WST Shares Purchased by Teacher Retirement System of Texas - MarketBeat
HB Wealth Management LLC Sells 3,325 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Portillo's, West Pharmaceutical, and Oracle: Overvalued Stocks After Recent GainsNews and Statistics - IndexBox
West Pharmaceutical announces up to $1B share repurchase program - MSN
West Pharmaceutical Services, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:WST) 2026-04-25 - Seeking Alpha
WST FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class ActionWST - TMX Newsfile
Barclays raises West Pharmaceutical price target on strong demand By Investing.com - Investing.com Nigeria
Research Alert: CFRA Raises Rating On West Pharmaceutical Services, Inc. To Buy From Hold - Moomoo
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Barclays raises West Pharmaceutical price target on strong demand - Investing.com
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
West Pharmaceutical Services Inc 주식 (WST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer |
Apr 27 '26 |
Sale |
305.20 |
2,817 |
859,753 |
16,828 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Option Exercise |
173.22 |
896 |
155,205 |
2,419 |
| Winters Chad | VP, Chief Accounting Officer |
Apr 27 '26 |
Sale |
300.67 |
896 |
269,399 |
1,523 |
자본화:
|
볼륨(24시간):